U.S. Software Stock News

NYSE:SN
NYSE:SNConsumer Durables

SharkNinja Adds New Accounting Leader As Shares Trade Below Targets

SharkNinja (NYSE:SN) has appointed Kaitlin Folan as Principal Accounting Officer and Chief Accounting Officer. Folan brings prior executive experience and extensive accounting expertise to the company’s finance leadership team. The change adds a new senior figure to SharkNinja’s financial oversight structure, which may interest current and prospective shareholders. For investors watching SharkNinja at a share price of $123.44, this leadership move sits alongside a mixed recent return...
NYSE:BH.A
NYSE:BH.AHospitality

Biglari Holdings Adds $500m Shelf To Fuel Growth And Flexibility

Biglari Holdings filed for a $500 million follow on equity offering and shelf registration. The filing covers the potential issuance of Class A and Class B Common Stock. The move gives the company flexibility to raise capital over time as conditions allow. For a company the size of Biglari Holdings, ticker NYSE:BH.A, a $500 million follow on shelf is a meaningful step, particularly with the stock at a current share price of $2,434.13. The filing directly relates to how the company might...
NasdaqCM:SIFY
NasdaqCM:SIFYTelecom

How Investors Are Reacting To Sify Technologies (SIFY) Data Center IPO Plans And Widening Losses

Sify Technologies reported third-quarter 2025 results with sales rising to INR 11,596 million from INR 10,491 million a year earlier, while net loss widened to INR 329 million. Management underscored strong data center momentum, plans for an IPO of its Sify Infinit Spaces subsidiary, and ongoing expansion highlighted by a new Karnataka facility, signalling a business model heavily geared toward capital-intensive infrastructure for AI-era demand. We’ll now examine how the planned IPO of Sify...
NasdaqGM:RAPT
NasdaqGM:RAPTBiotechs

GSK Buyout Turns Volatile RAPT Into Food Allergy Cash-Out Story

GSK has signed a definitive agreement to acquire RAPT Therapeutics (NasdaqGM:RAPT). The deal centers on ozureprubart, a long acting anti-IgE antibody in Phase IIb trials for food allergy prophylaxis. The transaction brings a food allergy candidate into GSK’s immunology and inflammation portfolio. RAPT Therapeutics, trading at $57.63, has recently seen very large 1 year returns and strong short term moves, with the share price up 64.2% over the past week and 60.8% over the past month. Year...
NasdaqCM:USAU
NasdaqCM:USAUMetals and Mining

Is It Too Late To Reassess U.S. Gold (USAU) After Its 207% One-Year Surge?

If you are wondering whether U.S. Gold's recent share price levels still make sense, you are not alone. This article will walk through what that price could imply about value. U.S. Gold last closed at US$22.60, with returns of 15.5% over 7 days, 0.6% over 30 days, 22.3% year to date and 207.1% over 1 year, as well as 361.2% over 3 years and 105.6% over 5 years. Those moves sit against a backdrop of ongoing interest in U.S. Gold as a materials stock, with investors reacting to sector...
NasdaqGS:BANF
NasdaqGS:BANFBanks

BancFirst (BANF) Net Interest Margin Near 3.8% Reinforces Bullish Profitability Narratives

BancFirst (BANF) has rounded out FY 2025 with Q4 revenue of US$182.7 million and basic EPS of US$1.78, while trailing twelve month revenue came in at US$685.0 million with EPS of US$7.22. The bank has seen revenue move from US$622.4 million and EPS of US$6.55 on a trailing basis a year earlier to the latest US$685.0 million and US$7.22 respectively, giving investors a clear sense of how the top line and EPS have tracked over the past year. With trailing net income of US$240.6 million and a...
NYSE:PJT
NYSE:PJTCapital Markets

Is It Too Late To Consider PJT Partners (PJT) After Its Strong Multi‑Year Rally?

If you are wondering whether PJT Partners at around US$181.61 is still good value after a strong run in recent years, you are not alone. The stock has had a mixed short term patch, with a 3.5% decline over the last 7 days, a 5.9% return over 30 days, 7.1% year to date, 11.1% over 1 year and a very large gain over 3 and 5 years. Recent news flow around PJT Partners has focused on its role as an independent advisory firm and its position in high profile restructuring and M&A assignments. This...
NasdaqGS:SYNA
NasdaqGS:SYNASemiconductor

Is Synaptics (SYNA) Fairly Priced After Recent Share Price Rebound?

If you are wondering whether Synaptics shares are offering fair value right now, it helps to look past the headlines and focus on what the numbers are actually saying. The stock last closed at US$85.60, with returns of 15.9% over 30 days and 13.0% year to date, although the 7 day return of a 6.0% decline and a 31.8% decline over three years show a mixed picture for longer term holders. Over the past year, Synaptics shares have returned 2.7%, while the 5 year return stands at a 13.7% decline...
NasdaqCM:AMPL
NasdaqCM:AMPLSoftware

Is Amplitude (AMPL) Priced Attractive After Recent Share Price Weakness?

If you are wondering whether Amplitude’s current share price really reflects what the business is worth, you are not alone. This article is built to unpack exactly that question in a clear, practical way. The stock closed at US$10.25, with a 3% gain over the last 7 days, but it is still showing a 14.2% decline over 30 days and a 9.9% decline over 1 year, with a 30.7% decline over 3 years and a 6.2% decline year to date. Recent news flow around Amplitude has focused on its position in product...
NasdaqGS:HTBK
NasdaqGS:HTBKBanks

Heritage Commerce (HTBK) Margin And Credit Improvements Challenge Premium P/E Concerns

Heritage Commerce (HTBK) has just wrapped up FY 2025 with fourth quarter revenue of US$53.0 million and basic EPS of US$0.25, alongside trailing twelve month revenue of US$195.6 million and EPS of US$0.78 that reflect the latest run rate. The company has seen revenue move from US$170.3 million to US$195.6 million on a trailing basis, while EPS shifted from US$0.66 to US$0.78. This sets up a picture in which firmer earnings and slightly higher net profit margins are central to how investors...
NYSE:AUB
NYSE:AUBBanks

Atlantic Union Bankshares Q4 Net Interest Margin Resilience Tests Bullish Narratives

Atlantic Union Bankshares (AUB) has wrapped up FY 2025 with fourth quarter total revenue of US$384.96 million and basic EPS of US$0.77, capping off a trailing twelve month run that delivered US$1.23 billion in revenue and EPS of US$2.03. Over recent quarters, the company has seen quarterly revenue move from US$200.98 million in Q4 2024 to US$195.69 million in Q1 2025, US$297.19 million in Q2, US$354.73 million in Q3, and US$384.96 million in Q4, while basic EPS tracked from US$0.61 to...